RNA-Seq of Circulating Tumor Cells in Stage II –III Breast Cancer
ConclusionIt is feasible to use RNA-seq of CTCs in non-metastatic patients to discover novel tumor biology characteristics.
Source: Annals of Surgical Oncology - Category: Cancer & Oncology Source Type: research
More News: Biology | Breast Cancer | Cancer | Cancer & Oncology | Genetics | HER2 | Molecular Biology | Nanotechnology